Stock comparison

BSXvsCVS

Boston Scientific CorpvsCVS Health Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BSX

Boston Scientific Corp

$64.87

-29.93%

Health Care$91.9BNYSE

CVS

CVS Health Corp

$76.43

-4.09%

Health Care$93.5BNYSE

60-day price, rebased to 100

BSX -30.83% · CVS +2.67%

Round-by-round

BSX 3·CVS 2· 1tie

EdgeCVS

Valuation upside

-27.90% vs +619.10% to DCF fair value

EdgeBSX

Balance-sheet strength

Altman Z 3.90 vs 2.31

EdgeBSX

Fundamental quality

Piotroski 9.00 vs 7.00 (of 9)

EdgeBSX

Growth + margins

Rule-of-40 36.80 vs 9.80

EdgeCVS

60-day momentum

-30.83% vs +2.67% price return

Tie

Market-cap liquidity

$91.9B vs $93.5B

Verdict

Across6categories,BSXtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBSXorCVS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.